BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND FANCC, ENSG00000158169, 2176, RP11-80I15_2, FAC, FA3, FACC, FLJ14675 AND Treatment
30395 results:

  • 1. Deciphering the progression of fine-needle aspiration: A bibliometric analysis of thyroid nodule research.
    Liu T; Yang F; Qiao J; Mao M
    Medicine (Baltimore); 2024 May; 103(20):e38059. PubMed ID: 38758913
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Current data and future perspectives on DNA methylation in ovarian cancer (Review).
    Fu M; Deng F; Chen J; Fu L; Lei J; Xu T; Chen Y; Zhou J; Gao Q; Ding H
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757340
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Intelligent nanovesicle for remodeling tumor microenvironment and circulating tumor chemoimmunotherapy amplification.
    Huai M; Wang Y; Li J; Pan J; Sun F; Zhang F; Zhang Y; Xu L
    J Nanobiotechnology; 2024 May; 22(1):257. PubMed ID: 38755645
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant Ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Feasibility and cost-effectiveness of genetic counselling for all patients with newly diagnosed ovarian cancer: a single-centre retrospective study.
    Schlootz S; Saner FAM; Rabaglio M; Imboden S; Wampfler J
    Swiss Med Wkly; 2024 Apr; 154():3386. PubMed ID: 38754016
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Rare Columnar Cell Variant of Papillary Thyroid Carcinoma with Cervical Spine Metastasis: A Case Report.
    Yu J; Yang G; Oh HY; Ryu YJ
    Curr Med Imaging; 2024; 20(1):e15734056300884. PubMed ID: 38752631
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Trends and projections of the global burden of thyroid cancer from 1990 to 2030.
    Hu S; Wu X; Jiang H
    J Glob Health; 2024 May; 14():04084. PubMed ID: 38751316
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Safety and efficacy of peptide receptor radionuclide therapy in neuroendocrine tumors: A single center experience.
    Sukrithan V; Armbruster H; Rogers S; Vogt SM; Grenade C; Verschraegen C; Zhou Y; Goyal A; Natwa M; Hussein A; Barr H; Konate D; Batdorf R; Brown A; Williams B; Zhao S; Wei L; Xu M; Shah MH; Konda B
    PLoS One; 2024; 19(5):e0298824. PubMed ID: 38748739
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer.
    Kim BG; Lee SH; Jang Y; Kang S; Kang CM; Cho NH
    J Transl Med; 2024 May; 22(1):453. PubMed ID: 38741142
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A Competing Risk Nomogram for Prediction of Prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 11. Genomic Profiling of Rare Undifferentiated Sarcomatoid Subtypes of Pancreatic Carcinomas: In Search of Therapeutic Targets.
    Faber EB; Krause HB; Amin K; Walker P; Hosein PJ; Shields AF; Lenz HJ; Prakash A; Goel S; Oberley M; Malleo G; Luchini C; Hwang J; Florou V; Garrido-Laguna I; Lou E
    JCO Precis Oncol; 2024 May; 8():e2300595. PubMed ID: 38723231
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.
    Zheng W; Tang X; Dong J; Feng J; Chen M; Zhu X
    Sci Rep; 2024 May; 14(1):10546. PubMed ID: 38719979
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Analysis of factors affecting the prognosis of patients with pancreatic cancer patients with obstructive jaundice].
    Zhang L; Li M; Sun QF; Yu HP
    Zhonghua Nei Ke Za Zhi; 2024 May; 63(5):474-479. PubMed ID: 38715484
    [No Abstract]    [Full Text] [Related]  

  • 14. treatment strategies for borderline resectable pancreatic neuroendocrine tumors: a narrative review.
    Chang JY; Ruff SM; Cloyd JM
    Chin Clin Oncol; 2024 Apr; 13(2):25. PubMed ID: 38711178
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
    Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
    Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Physical function as a predictor of chemotherapy-induced peripheral neuropathy in patients with pancreatic cancer.
    Lin KY; Chen PS; Lin CF
    BMC Gastroenterol; 2024 May; 24(1):154. PubMed ID: 38711006
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC treatment.
    Shinde A; Panchal K; Patra P; Singh S; Enakolla S; Paliwal R; Chaurasiya A
    AAPS PharmSciTech; 2024 May; 25(5):97. PubMed ID: 38710894
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Active surveillance is a feasible and safe strategy in selected patients with papillary thyroid cancer and suspicious cervical lymph nodes detected after thyroidectomy.
    Solórzano M; Lustig N; Mosso L; Espinoza M; Santana R; Gonzalez H; Montero PH; Cruz F; Solar A; Domínguez JM
    Arch Endocrinol Metab; 2024 May; 68():e230146. PubMed ID: 38709151
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial.
    Li X; Cao J; Wang W; Zhu X; Sun Y; Song L; Zhang W; Han Y
    Front Endocrinol (Lausanne); 2024; 15():1310223. PubMed ID: 38706697
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Perioperative management of a patient with unexpectedly detected early-stage ovarian mucinous carcinoma combined with progressive bulbar paralysis: a case report and literature review.
    Zhang D; Xu R; Huo T; Liu Y; Hao Z; Sun Y; Xi X; Du X; Wang L; Du J
    BMC Womens Health; 2024 May; 24(1):274. PubMed ID: 38704534
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1520.